Preeclampsia and eclampsia: Enhanced detection and treatment for morbidity reduction.

Best Pract Res Clin Anaesthesiol

Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, L1, Boston, MA, 02115, USA. Electronic address:

Published: September 2024

Preeclampsia is a life-threatening complication that develops in 2-8% of pregnancies. It is characterized by elevated blood pressure after 20 weeks of gestation and may progress to multiorgan dysfunction, leading to severe maternal and fetal morbidity and mortality. The only definitive treatment is delivery, and efforts are focused on early risk prediction, surveillance, and severity mitigation. Anesthesiologists, as part of the interdisciplinary team, should evaluate patients early in labor in order to optimize cardiovascular, pulmonary, and coagulation status. Neuraxial techniques are safe in the absence of coagulopathy and aid avoidance of general anesthesia, which is associated with high risk in these patients. This review aims to provide anaesthesiologists with a comprehensive update on the latest strategies and evidence-based practices for managing preeclampsia, with an emphasis on perioperative care.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707392PMC
http://dx.doi.org/10.1016/j.bpa.2024.11.001DOI Listing

Publication Analysis

Top Keywords

preeclampsia eclampsia
4
eclampsia enhanced
4
enhanced detection
4
detection treatment
4
treatment morbidity
4
morbidity reduction
4
reduction preeclampsia
4
preeclampsia life-threatening
4
life-threatening complication
4
complication develops
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!